Inversine

Targacept and AstraZeneca Announce Global License and Research ... Dec 31, 2005
Drug Newswire (press release), Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in clinical development for cognitive impairment, including ...

Targacept, AstraZeneca Enter TC-1734 Deal For Up To $300M Dec 28, 2005
BioWorld Online (subscription), Targacept has one marketed product, Inversine (mecamylamine hydrochloride), which was acquired from Sunnyvale, Calif.-based Layton Bioscience Inc. ...